Sound Pharmaceuticals and the University of Florida begin enrollment on a Phase II study with SPI-1005 to prevent and treat noise induced hearing loss

By Sound PharmaDecember 5, 2012June 20th, 2016Uncategorized

Home » News » Sound Pharmaceuticals and the University of Florida begin enrollment on a Phase II study with SPI-1005 to prevent and treat noise induced hearing loss

– 2012-12-05_ClinicalTrialStart

Sound Pharmaceuticals and the University of Florida begin enrollment on a Phase II study with SPI-1005 to prevent and treat noise induced hearing loss

Archives

Contact Us

Address:

Phone:

Email:

Disclosures

Other resources